Works by Mori, Masahide


Results: 63
    1
    2
    3

    A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2
    By:
    • Iwahori, Kota;
    • Nii, Takuro;
    • Yamaguchi, Norihiko;
    • Kawasaki, Takahiro;
    • Okamura, Satomi;
    • Hashimoto, Kazuki;
    • Matsuki, Takanori;
    • Tsujino, Kazuyuki;
    • Miki, Keisuke;
    • Osa, Akio;
    • Goya, Sho;
    • Abe, Kinya;
    • Mori, Masahide;
    • Takeda, Yoshito;
    • Yamada, Tomomi;
    • Kida, Hiroshi;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    4

    Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45337-3
    By:
    • Masuda, Takeshi;
    • Miura, Satoru;
    • Sato, Yuki;
    • Tachihara, Motoko;
    • Bessho, Akihiro;
    • Nakamura, Atsushi;
    • Miyawaki, Taichi;
    • Yoshimine, Kohei;
    • Mori, Masahide;
    • Shiraishi, Hideaki;
    • Hamai, Kosuke;
    • Haratani, Koji;
    • Maeda, Sumiko;
    • Tabata, Eriko;
    • Kitagawa, Chiyoe;
    • Tanizaki, Junko;
    • Imai, Takumi;
    • Nogami, Shohei;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    5

    A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2
    By:
    • Iwahori, Kota;
    • Nii, Takuro;
    • Yamaguchi, Norihiko;
    • Kawasaki, Takahiro;
    • Okamura, Satomi;
    • Hashimoto, Kazuki;
    • Matsuki, Takanori;
    • Tsujino, Kazuyuki;
    • Miki, Keisuke;
    • Osa, Akio;
    • Goya, Sho;
    • Abe, Kinya;
    • Mori, Masahide;
    • Takeda, Yoshito;
    • Yamada, Tomomi;
    • Kida, Hiroshi;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    6

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    7
    8
    9
    10

    A case of acute and severe thrombocytopenia due to readministration of rifampicin.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 2, p. 288, doi. 10.1007/s10156-010-0117-x
    By:
    • Mori, Masahide;
    • Izawa, Kazutaka;
    • Fujikawa, Takeya;
    • Uenami, Takeshi;
    • Sugano, Teppei;
    • Kagami, Sin-ichi;
    • Namba, Yoshinobu;
    • Yano, Yukihiro;
    • Yoneda, Tsutomu;
    • Kitada, Seigo;
    • Kimura, Hiromi;
    • Yamaguchi, Toshihiko;
    • Yokota, Soichiro;
    • Maekura, Ryoji
    Publication type:
    Article
    11

    Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens.

    Published in:
    Modern Rheumatology, 2010, v. 20, n. 2, p. 130, doi. 10.3109/s10165-009-0243-4
    By:
    • Ogata, Atsushi;
    • Mori, Masahide;
    • Hashimoto, Shoji;
    • Yano, Yukihiro;
    • Fujikawa, Takeya;
    • Kawai, Mari;
    • Kuwahara, Yusuke;
    • Hirano, Toru;
    • Arimitsu, Junsuke;
    • Hagihara, Keisuke;
    • Shima, Yoshihito;
    • Narazaki, Masashi;
    • Yokota, Souichirou;
    • Kishimoto, Tadamitsu;
    • Kawase, Ichiro;
    • Tanaka, Toshio
    Publication type:
    Article
    12
    13
    14
    15

    Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
    By:
    • Shimokawa, Mototsugu;
    • Kanazu, Masaki;
    • Saito, Ryusei;
    • Mori, Masahide;
    • Tamura, Atsuhisa;
    • Okano, Yoshio;
    • Fujita, Yuka;
    • Endo, Takeo;
    • Motegi, Mitsuru;
    • Takata, Shohei;
    • Kita, Toshiyuki;
    • Sukoh, Noriaki;
    • Mizuki, Fumitaka;
    • Takenoyama, Mitsuhiro;
    • Atagi, Shinji
    Publication type:
    Article
    16
    17

    A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1827, doi. 10.1111/1759-7714.14465
    By:
    • Asami, Kazuhiro;
    • Ando, Masahiko;
    • Nishimura, Takashi;
    • Yokoi, Takashi;
    • Tamura, Atsuhisa;
    • Minato, Koichi;
    • Mori, Masahide;
    • Ogushi, Fumitaka;
    • Yamamoto, Akiyoshi;
    • Yoshioka, Hiroshige;
    • Kawahara, Masaaki;
    • Atagi, Shinji
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity.

    Published in:
    Clinical Lung Cancer, 2013, v. 14, n. 5, p. 502, doi. 10.1016/j.cllc.2013.03.003
    By:
    • Takayuki Takimoto;
    • Takashi Kijima;
    • Yasushi Otani;
    • Shinpei Nonen;
    • Yoshinobu Namba;
    • Masahide Mori;
    • Soichiro Yokota;
    • Seigo Minami;
    • Kiyoshi Komuta;
    • Junji Uchida;
    • Fumio Imamura;
    • Mitsugi Furukawa;
    • Naotoshi Tsuruta;
    • Yasushi Fujio;
    • Junichi Azuma;
    • Isao Tachibana;
    • Atsushi Kumanogoh
    Publication type:
    Article
    30
    31
    32

    Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

    Published in:
    PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0220570
    By:
    • Ryuya Edahiro;
    • Masaki Kanazu;
    • Hiroyuki Kurebe;
    • Masahide Mori;
    • Daichi Fujimoto;
    • Yoshihiko Taniguchi;
    • Hidekazu Suzuki;
    • Katsuya Hirano;
    • Toshihide Yokoyama;
    • Mitsunori Morita;
    • Yasushi Fukuda;
    • Junji Uchida;
    • Takeshi Makio;
    • Motohiro Tamiya
    Publication type:
    Article
    33
    34
    35

    Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.

    Published in:
    2017
    By:
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Seigo;
    • Takata, So;
    • Masuhiro, Kentaro;
    • Futami-Nishijima, Yu;
    • Uenami, Takeshi;
    • Mori, Masahide;
    • Koba, Taro;
    • Matsuki, Takanori;
    • Takimoto, Takayuki;
    • Suzuki, Hidekazu;
    • Okamoto, Norio;
    • Komuta, Kiyoshi;
    • Hirashima, Tomonori;
    • Kumanogoh, Atsushi;
    • Kijima, Takashi
    Publication type:
    journal article
    36

    Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58186-7
    By:
    • Tanaka, Kentaro;
    • Sugisaka, Jun;
    • Shiraishi, Yoshimasa;
    • Watanabe, Yasutaka;
    • Daga, Haruko;
    • Azuma, Koichi;
    • Nishino, Kazumi;
    • Mori, Masahide;
    • Ota, Takayo;
    • Saito, Haruhiro;
    • Hata, Akito;
    • Sakaguchi, Tadashi;
    • Kozuki, Toshiyuki;
    • Akamatsu, Hiroaki;
    • Matsumoto, Hirotaka;
    • Tachihara, Motoko;
    • Wakuda, Kazushige;
    • Sato, Yuki;
    • Ozaki, Tomohiro;
    • Tsuchiya-Kawano, Yuko
    Publication type:
    Article
    37
    38

    Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251318850
    By:
    • Tanzawa, Shigeru;
    • Yoshioka, Hiroshige;
    • Misumi, Toshihiro;
    • Miyauchi, Eisaku;
    • Ninomiya, Kiichiro;
    • Murata, Yasunori;
    • Takeshita, Masafumi;
    • Kinoshita, Fumihiko;
    • Fujishita, Takatoshi;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Hashimoto, Kazuki;
    • Mori, Masahide;
    • Miyanaga, Akihiko;
    • Hayashi, Anna;
    • Tanaka, Hisashi;
    • Honda, Ryoichi;
    • Nojiri, Masafumi;
    • Sato, Yuki;
    • Hata, Akito
    Publication type:
    Article
    39

    Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 12, p. e2347700, doi. 10.1001/jamanetworkopen.2023.47700
    By:
    • Sakamoto, Tomohiro;
    • Matsubara, Taichi;
    • Takahama, Takayuki;
    • Yokoyama, Toshihide;
    • Nakamura, Atsushi;
    • Tokito, Takaaki;
    • Okamoto, Tatsuro;
    • Akamatsu, Hiroaki;
    • Oki, Masahide;
    • Sato, Yuki;
    • Tobino, Kazunori;
    • Ikeda, Satoshi;
    • Mori, Masahide;
    • Mimura, Chihiro;
    • Maeno, Ken;
    • Miura, Satoru;
    • Harada, Toshiyuki;
    • Nishimura, Kunihiro;
    • Hiraoka, Manabu;
    • Kenmotsu, Hirotsugu
    Publication type:
    Article
    40
    41
    42

    NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 3, p. 1155, doi. 10.3390/ijms26031155
    By:
    • Naito, Maiko;
    • Takeda, Yoshito;
    • Edahiro, Ryuya;
    • Shirai, Yuya;
    • Enomoto, Takatoshi;
    • Nakayama, Mana;
    • Nojima, Satoshi;
    • Nogami-Ito, Mari;
    • Mori, Masahide;
    • Yano, Yukihiro;
    • Matsuki, Takanori;
    • Yoshimura, Hanako;
    • Hara, Reina;
    • Yamamoto, Makoto;
    • Masuhiro, Kentaro;
    • Naito, Yujiro;
    • Koyama, Shohei;
    • Iwahori, Kota;
    • Nagatomo, Izumi;
    • Shiroyama, Takayuki
    Publication type:
    Article
    43

    Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
    By:
    • Matsumoto, Kinnosuke;
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Toshiyuki;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suga, Yasuhiko;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Namba, Yoshinobu;
    • Tetsumoto, Satoshi;
    • Niki, Toshie;
    • Morimura, Osamu;
    • Osa, Akio;
    • Nishino, Kazumi;
    • Nagatomo, Izumi;
    • Takeda, Yoshito
    Publication type:
    Article
    44

    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    Published in:
    BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Harada, Daijiro;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    45
    46

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    47

    Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense.

    Published in:
    2022
    By:
    • Tomoki Kuge;
    • Kiyoharu Fukushima;
    • Yuki Matsumoto;
    • Haruko Saito;
    • Yuko Abe;
    • Eri Akiba;
    • Kako Haduki;
    • Tadayoshi Nitta;
    • Akira Kawano;
    • Michio Tanaka;
    • Yumi Hattori;
    • Takahiro Kawasaki;
    • Takanori Matsuki;
    • Takayuki Shiroyama;
    • Daisuke Motooka;
    • Kazuyuki Tsujino;
    • Keisuke Miki;
    • Masahide Mori;
    • Seigo Kitada;
    • Shota Nakamura
    Publication type:
    journal article
    48

    WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.

    Published in:
    International Journal of Cancer, 2009, v. 125, n. 2, p. 381, doi. 10.1002/ijc.24367
    By:
    • Oji, Yusuke;
    • Kitamura, Yayoi;
    • Kamino, Eriko;
    • Kitano, Aiko;
    • Sawabata, Noriyoshi;
    • Inoue, Masayoshi;
    • Mori, Masahide;
    • Nakatsuka, Shin-ichi;
    • Sakaguchi, Nao;
    • Miyazaki, Kaori;
    • Nakamura, Michiyo;
    • Fukuda, Ikuyo;
    • Nakamura, Junya;
    • Tatsumi, Naoya;
    • Takakuwa, Tetsuya;
    • Nishida, Sumiyuki;
    • Shirakata, Toshiaki;
    • Hosen, Naoki;
    • Tsuboi, Akihiro;
    • Nezu, Riichiro
    Publication type:
    Article
    49
    50